Niitsu, N <br/><br/>
THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: a prospective study.  [electronic resource] 

 -  Leukemia  Nov 1997 
 - 1817-20 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2400001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Prospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage